Healthcare Health/Fitness
Blackstone to sell its stake in Indian drug maker Emcure Pharma to Bain Capital for INR650 crore
Private equity firm Blackstone Group has put up for sale its 13.09% stake in Indian drug company Emcure Pharmaceuticals. The stake will be sold to rival private equity firm Bain Capital for INR650 crore.
Private equity firm Carlyle Group has acquired a minority stake of 28% in Indian super-specialty hospital chain Global Health for INR960 crore
Private equity firm Carlyle Group has acquired a minority stake of 28% in Indian super-specialty hospital chain Global Health for INR960 crore. Carlyle as of September this year had invested $1.1 billion in India.
Synapse Biomedical wins $2.4M from Ohio Third Frontier Commission
The Ohio Third Frontier Commission has awarded Synapse Biomedical with $2.4 million to further the design and development of its NeuRx technology, a platform that is used to treat patients with respiratory insufficiency.
Bayer to acquire Algeta in $2.9 B deal
Germany-based healthcare and agricultural products company Bayer said it will be buying Norway-based Algeta, its partner in developing a prostate cancer therapy, in a deal worth $2.9 billion, Bloomberg reported.